POLO

Study / Research

A randomized trial that studied Olaparib in pancreatic cancer patients with BRCA mutations, showing progression-free survival but no overall survival benefit.

Mentioned in 1 video

Videos Mentioning POLO

#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy

#133 - Vinay Prasad, M.D., M.P.H: Hallmarks of successful cancer policy

Peter Attia MD

A randomized trial that studied Olaparib in pancreatic cancer patients with BRCA mutations, showing progression-free survival but no overall survival benefit.